𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson’s disease

✍ Scribed by Yu Watanabe; Hiroyuki Kato; Tsutomu Araki


Publisher
Springer
Year
2007
Tongue
English
Weight
556 KB
Volume
23
Category
Article
ISSN
0885-7490

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Neuroprotective effects of (±)-kavain in
✍ Nicole Schmidt; Boris Ferger 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

This is the first study to investigate the potential protective effects of the lipophilic kavapyrone (+/-)-kavain in the experimental MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD). Male C57BL/6 mice were treated with (+/-)-kavain (50, 100, or 200 mg/kg i.p.) o

Hexokinase II gene transfer protects aga
✍ Juan Carlos Corona; Alfredo Gimenez-Cassina; Filip Lim; Javier Díaz-Nido 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

## Abstract A typical feature of Parkinson's disease is the progressive loss of dopaminergic neurons in the substantia nigra, in which inhibition of mitochondrial complex I activity may play an important role. Rotenone or 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) inhibit the mitochondrial

Identification of alternate transcripts
✍ Thomas J. Giove; Monika M. Deshpande; William D. Eldred 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB 👁 2 views

## Abstract Nitric oxide (NO) is a major signaling molecule in the retina and CNS, with physiological roles in every cell type in the retina. Previous work shows that neuronal nitric oxide synthase (nNOS) is an important source of NO in the vertebrate retina. There are distinct, active alternative